"Fluorescein Angiography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
| Descriptor ID |
D005451
|
| MeSH Number(s) |
E01.370.370.050.350 E01.370.380.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluorescein Angiography".
Below are MeSH descriptors whose meaning is more specific than "Fluorescein Angiography".
This graph shows the total number of publications written about "Fluorescein Angiography" by people in this website by year, and whether "Fluorescein Angiography" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 5 | 5 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 3 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 0 | 3 | 3 |
| 2021 | 2 | 5 | 7 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 4 | 4 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorescein Angiography" by people in Profiles.
-
Case series: The role of retinal ischemia in the pathogenesis and clinical manifestation of diabetic retinopathy. Optom Vis Sci. 2026 Aug; 103(8):e70090.
-
Case series: The value of fundus autofluorescence in inherited macular disease. Optom Vis Sci. 2026 Mar; 103(3):e70036.
-
Logistical, Ethical, and Technical Considerations in the World's First Face and Whole Eye Transplantation. Plast Reconstr Surg. 2026 08 01; 158(2):302e-310e.
-
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. Ophthalmology. 2026 04; 133(4):451-465.
-
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. BMJ Open Ophthalmol. 2025 07 07; 10(1).
-
Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study. BMC Ophthalmol. 2025 Jan 17; 25(1):24.
-
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024 09; 131(9):1107-1120.
-
Therapies for Geographic Atrophy. Int Ophthalmol Clin. 2024 01 01; 64(1):5-20.
-
Update on the Management of Central Serous Chorioretinopathy. Int Ophthalmol Clin. 2024 Jan 01; 64(1):179-193.
-
Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography. J Vis Exp. 2023 08 11; (198).